Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, May 14, 2020
[ Thu, May 14th 2020
] - WOPRAI
[ Thu, May 14th 2020
] - WOPRAI
[ Thu, May 14th 2020
] - WOPRAI
[ Thu, May 14th 2020
] - WOPRAI
[ Thu, May 14th 2020
] - WOPRAI
[ Thu, May 14th 2020
] - WOPRAI
[ Thu, May 14th 2020
] - WOPRAI
Wed, May 13, 2020
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
[ Wed, May 13th 2020
] - WOPRAI
Marc Frahm Initiated (TBPH) at Buy and Held Target at $42 on, May 13th, 2020
Marc Frahm of Cowen & Co., Initiated "Theravance Biopharma, Inc." (TBPH) at Buy and Held Target at $42 on, May 13th, 2020.
Marc has made no other calls on TBPH in the last 4 months.
There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with Marc's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Marc
- Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $32 on, Tuesday, February 25th, 2020
- Tyler Van Buren of "Piper Sandler" Maintained at Buy with Decreased Target to $35 on, Tuesday, February 25th, 2020
